RxSight, Inc. (RXST)
Makes intraocular lenses that doctors can adjust with light after cataract surgery.
$6.05+0.07%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-22.4%
The outlook
RXST is trading near its 52-week lows, with the average analyst price target sitting about 33% above the current price of $6.05. Analyst consensus leans toward Hold, and the stock is showing mixed momentum against its moving averages. Overall sentiment remains neutral, with modest coverage among eight analysts.
What’s behind the score
Analyst consensusHold — 3.1 avg of 8 analysts
Price trendMixed vs its moving averages
52-week range18% of the way from its 52-week low to high
Price targetAvg target +33% vs current price
Analyst price target
~12-month · 8 analysts$8.06average target+33.3% vs now
Now $6.05
Low $5.50High $11.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$250.4M
52-wk high
$13.22
52-wk low
$4.48
50-day avg
$5.29
200-day avg
$7.88
Trailing P/E
—